Sort by
Refine Your Search
-
Program
-
Employer
-
Field
-
of surveys to support risk assessment studies. Investigative studies aimed at the identifying the source of residue contamination and strategies of mitigation. Contribution to management of staff, resources
-
of early brain injury and Cerebral Palsy. The ELEVATE programme, which comprises 4 key research pillars, aims to identify risk factors of Cerebral Palsy early, to prevent Cerebral Palsy, and to reduce the
-
of early brain injury and Cerebral Palsy. The ELEVATE programme, which comprises 4 key research pillars, aims to identify risk factors of Cerebral Palsy early, to prevent Cerebral Palsy, and to reduce the
-
comply with the programme’s eligibility criteria and mobility rule . Researchers at Risk are encouraged to apply. All candidates must discuss their research idea and proposal and seek the support of
-
a chance to be involved in a transformative project that can have a lasting impact on sustainable community development. Salary Range: €31,150 - €36,554 Per Annum Appointment on the above range will
-
to identify risk factors of Cerebral Palsy early, to prevent Cerebral Palsy, and to reduce the severity of the condition when it does occur. By targeting the earliest possible interventions and proactively
-
Clinical Assessments (JCAs) undertaken by experts from HTA bodies across the EU will provide assessments of selected high-risk medical devices and diagnostics. A JCA will comprise a description of the
-
nationality and gender; Be a researcher with career breaks or; Be a researcher at Risk (Researcher displaced by conflict); NOT have resided or carried out their main activity (work or study) in
-
leading all aspects of a research project [e.g. dealing with stakeholders, quality control, financial and resource planning, risk management, ethics procedures and communication] Experience of economic
-
estimates of the true prevalence of micronutrient deficiencies, based on priority biomarker and micronutrient intake data in European populations and their associated health costs, focused on high-risk